Topics

Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

10:12 EST 3 Feb 2020 | Pharmaceutical Technology

Advanced technologies provider Catalent has acquired cell and gene therapy manufacturer MaSTherCell Global for $315m in cash. The transaction is...
Read More...

The post Catalent acquires cell and gene therapy-focused MaSTherCell for $315m appeared first on Pharmaceutical Technology.

Original Article: Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

NEXT ARTICLE

More From BioPortfolio on "Catalent acquires cell and gene therapy-focused MaSTherCell for $315m"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...